Download PDF
Am J Perinatol 2025; 42(08): 1066-1072
DOI: 10.1055/a-2461-5295
Original Article

In-Hospital Outcomes of Neonates with Hypoxic–Ischemic Encephalopathy Receiving Sedation–Analgesia during Therapeutic Hypothermia

Mary E. Pease 
1   Division of Neonatology, St. Christopher's Hospital for Children, Philadelphia, Pennsylvania
2   Children's Hospital of Philadelphia at Main Line Health, Bryn Mawr Hospital, Bryn Mawr, Pennsylvania
,
Erica Yi
3   Department of Pediatrics, Drexel University College of Medicine, Philadelphia, Pennsylvania
,
Swosti Joshi
1   Division of Neonatology, St. Christopher's Hospital for Children, Philadelphia, Pennsylvania
3   Department of Pediatrics, Drexel University College of Medicine, Philadelphia, Pennsylvania
,
Erica Poletto
4   Department of Radiology, Cooper University Health System, Camden, New Jersey
5   Pediatric Radiology, Cooper medical School of Rowan University, Camden, New Jersey
,
Ogechukwu Menkiti
1   Division of Neonatology, St. Christopher's Hospital for Children, Philadelphia, Pennsylvania
3   Department of Pediatrics, Drexel University College of Medicine, Philadelphia, Pennsylvania
,
Vilmaris Quiñones Cardona 
1   Division of Neonatology, St. Christopher's Hospital for Children, Philadelphia, Pennsylvania
3   Department of Pediatrics, Drexel University College of Medicine, Philadelphia, Pennsylvania
› Author Affiliations Funding None.
› Further Information
Also available at
    Permissions and Reprints

Abstract

Objective

This study aimed to compare magnetic resonance imaging (MRI) severity scores and in-hospital outcomes among neonates with perinatal hypoxic–ischemic encephalopathy (HIE) with and without exposure to sedation–analgesia (SA) during therapeutic hypothermia (TH).

Study Design

A single-center, retrospective cohort study of neonates with perinatal HIE undergoing TH between January 2010 and December 2020. Demographics, clinical characteristics, MRI scores, and in-hospital outcomes were compared between patients without SA exposure and those with SA use.

Results

Of the 131 neonates, 55 (42%) did not have SA exposure, and 76 (58%) had SA during TH. Groups were similar in birth weight, gestational age, and severity of HIE. A higher proportion of neonates in the SA group received inhaled nitric oxide (iNO, 39.4 vs. 2%, p < 0.001) and vasopressors (41 vs. 20%, p = 0.012) compared to no SA group. There was no difference in median MRI severity scores for neither T1 (2 [2, 4.25] vs. 3 [2, 6], p = 0.295), T2 (2 [0, 3] vs. 3 [1.5, 5.5], p = 0.088) nor diffusion-weighted images (0 [0, 2] vs. 0 [0, 4.25], p = 0.090) between SA and no SA groups, respectively. In-hospital outcomes were similar between groups except for lower survival to discharge (87 vs. 98%, p = 0.020) in the SA group compared to those without SA. A regression analysis showed death was associated with the concomitant use of iNO (p < 0.001) and inotropes (p < 0.001).

Conclusion

SA during TH for perinatal HIE did not alter early MRI severity scores. A lower survival to discharge in the SA group may be related to illness severity rather than SA use alone.

Key Points

  • Conflicting studies exist regarding the efficacy of SA use during TH.

  • SA use during TH did not alter in-hospital MRI severity scores.

  • SA use was associated with a lower survival to discharge, correlated to the severity of illness rather than SA use alone.

Keywords

therapeutic hypothermia - hypoxic–ischemic encephalopathy - sedation - analgesia - neonates - MRI severity scores - hospital outcomes

Supplementary Material



Publication History

Received: 29 March 2024

Accepted: 04 November 2024

Article published online:
25 November 2024

© 2024. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Rainaldi MA, Perlman JM. Pathophysiology of birth asphyxia. Clin Perinatol 2016; 43 (03) 409-422
    CrossrefPubMedSearch in Google Scholar
  • 2 Kurinczuk JJ, White-Koning M, Badawi N. Epidemiology of neonatal encephalopathy and hypoxic-ischaemic encephalopathy. Early Hum Dev 2010; 86 (06) 329-338
    CrossrefPubMedSearch in Google Scholar
  • 3 Azzopardi DV, Strohm B, Edwards AD. et al; TOBY Study Group. Moderate hypothermia to treat perinatal asphyxial encephalopathy. N Engl J Med 2009; 361 (14) 1349-1358
    CrossrefPubMedSearch in Google Scholar
  • 4 Azzopardi D, Strohm B, Marlow N. et al; TOBY Study Group. Effects of hypothermia for perinatal asphyxia on childhood outcomes. N Engl J Med 2014; 371 (02) 140-149
    CrossrefPubMedSearch in Google Scholar
  • 5 Edwards AD, Brocklehurst P, Gunn AJ. et al. Neurological outcomes at 18 months of age after moderate hypothermia for perinatal hypoxic ischaemic encephalopathy: synthesis and meta-analysis of trial data. BMJ 2010; 340: c363
    CrossrefPubMedSearch in Google Scholar
  • 6 Gluckman PD, Wyatt JS, Azzopardi D. et al. Selective head cooling with mild systemic hypothermia after neonatal encephalopathy: multicentre randomised trial. Lancet 2005; 365 (9460) 663-670
    CrossrefPubMedSearch in Google Scholar
  • 7 Shankaran S, Laptook AR, Ehrenkranz RA. et al; National Institute of Child Health and Human Development Neonatal Research Network. Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy. N Engl J Med 2005; 353 (15) 1574-1584
    CrossrefPubMedSearch in Google Scholar
  • 8 Shankaran S, Pappas A, McDonald SA. et al; Eunice Kennedy Shriver NICHD Neonatal Research Network. Childhood outcomes after hypothermia for neonatal encephalopathy. N Engl J Med 2012; 366 (22) 2085-2092
    CrossrefPubMedSearch in Google Scholar
  • 9 Quinones Cardona V, Rao R, Zaniletti I. et al; Children's Hospitals Neonatal Consortium. Association of hospital resource utilization with neurodevelopmental outcomes in neonates with hypoxic-ischemic encephalopathy. JAMA Netw Open 2023; 6 (03) e233770
    CrossrefPubMedSearch in Google Scholar
  • 10 Wassink G, Lear CA, Gunn KC, Dean JM, Bennet L, Gunn AJ. Analgesics, sedatives, anticonvulsant drugs, and the cooled brain. Semin Fetal Neonatal Med 2015; 20 (02) 109-114
    CrossrefPubMedSearch in Google Scholar
  • 11 Thoresen M, Satas S, Løberg EM. et al. Twenty-four hours of mild hypothermia in unsedated newborn pigs starting after a severe global hypoxic-ischemic insult is not neuroprotective. Pediatr Res 2001; 50 (03) 405-411
    CrossrefPubMedSearch in Google Scholar
  • 12 Lemyre B, Chau V. Hypothermia for newborns with hypoxic-ischemic encephalopathy. Paediatr Child Health 2018; 23 (04) 285-291
    CrossrefPubMedSearch in Google Scholar
  • 13 Montaldo P, Vakharia A, Ivain P. et al. Pre-emptive opioid sedation during therapeutic hypothermia. Arch Dis Child Fetal Neonatal Ed 2020; 105 (01) 108-109
    CrossrefPubMedSearch in Google Scholar
  • 14 Simons SH, van Dijk M, van Lingen RA. et al. Randomised controlled trial evaluating effects of morphine on plasma adrenaline/noradrenaline concentrations in newborns. Arch Dis Child Fetal Neonatal Ed 2005; 90 (01) F36-F40
    CrossrefPubMedSearch in Google Scholar
  • 15 Liow N, Montaldo P, Lally PJ. et al. Preemptive morphine during therapeutic hypothermia after neonatal encephalopathy: a secondary analysis. Ther Hypothermia Temp Manag 2020; 10 (01) 45-52
    CrossrefPubMedSearch in Google Scholar
  • 16 Natarajan G, Hamrick SE, Zaniletti I. et al; Children's Hospitals Neonatal Database Hypoxic-Ischemic Encephalopathy Focus group. Opioid exposure during therapeutic hypothermia and short-term outcomes in neonatal encephalopathy. J Perinatol 2022; 42 (08) 1017-1025
    CrossrefPubMedSearch in Google Scholar
  • 17 Angeles DM, Wycliffe N, Michelson D. et al. Use of opioids in asphyxiated term neonates: effects on neuroimaging and clinical outcome. Pediatr Res 2005; 57 (06) 873-878
    CrossrefPubMedSearch in Google Scholar
  • 18 McPherson C, Frymoyer A, Ortinau CM, Miller SP, Groenendaal F. Newborn Brain Society Guidelines and Publications Committee. Management of comfort and sedation in neonates with neonatal encephalopathy treated with therapeutic hypothermia. Semin Fetal Neonatal Med 2021; 26 (04) 101264
    CrossrefPubMedSearch in Google Scholar
  • 19 Shankaran S, Natarajan G, Chalak L, Pappas A, McDonald SA, Laptook AR. Hypothermia for neonatal hypoxic-ischemic encephalopathy: NICHD Neonatal Research Network contribution to the field. Semin Perinatol 2016; 40 (06) 385-390
    CrossrefPubMedSearch in Google Scholar
  • 20 McMillan D, Wu J. Approach to the bleeding newborn. Paediatr Child Health 1998; 3 (06) 399-401
    CrossrefPubMedSearch in Google Scholar
  • 21 Barkovich AJ, Hajnal BL, Vigneron D. et al. Prediction of neuromotor outcome in perinatal asphyxia: evaluation of MR scoring systems. AJNR Am J Neuroradiol 1998; 19 (01) 143-149
    PubMedSearch in Google Scholar
  • 22 Berube MW, Lemmon ME, Pizoli CE. et al. Opioid and benzodiazepine use during therapeutic hypothermia in encephalopathic neonates. J Perinatol 2020; 40 (01) 79-88
    CrossrefPubMedSearch in Google Scholar
  • 23 Steinman KJ, Gorno-Tempini ML, Glidden DV. et al. Neonatal watershed brain injury on magnetic resonance imaging correlates with verbal IQ at 4 years. Pediatrics 2009; 123 (03) 1025-1030
    CrossrefPubMedSearch in Google Scholar
  • 24 Al Amrani F, Marcovitz J, Sanon PN. et al. Prediction of outcome in asphyxiated newborns treated with hypothermia: is a MRI scoring system described before the cooling era still useful?. Eur J Paediatr Neurol 2018; 22 (03) 387-395
    CrossrefPubMedSearch in Google Scholar
  • 25 Ní Bhroin M, Kelly L, Sweetman D. et al. Relationship between MRI scoring systems and neurodevelopmental outcome at two years in infants with neonatal encephalopathy. Pediatr Neurol 2022; 126: 35-42
    CrossrefPubMedSearch in Google Scholar
  • 26 Gundersen JK, Chakkarapani E, Jary S. et al. Morphine and fentanyl exposure during therapeutic hypothermia does not impair neurodevelopment. EClinicalMedicine 2021; 36: 100892
    CrossrefPubMedSearch in Google Scholar
  • 27 Mahdi Z, Marandyuk B, Desnous B. et al. Opioid analgesia and temperature regulation are associated with EEG background activity and MRI outcomes in neonates with mild-to-moderate hypoxic-ischemic encephalopathy undergoing therapeutic hypothermia. Eur J Paediatr Neurol 2022; 39: 11-18
    CrossrefPubMedSearch in Google Scholar
  • 28 Finder M, Boylan GB, Twomey D, Ahearne C, Murray DM, Hallberg B. Two-year neurodevelopmental outcomes after mild hypoxic ischemic encephalopathy in the era of therapeutic hypothermia. JAMA Pediatr 2020; 174 (01) 48-55
    CrossrefPubMedSearch in Google Scholar
  • 29 Natarajan G, Shankaran S, Laptook AR. et al; NICHD Neonatal Research Network (NRN) Whole Body Hypothermia Subcommittee. Association between sedation-analgesia and neurodevelopment outcomes in neonatal hypoxic-ischemic encephalopathy. J Perinatol 2018; 38 (08) 1060-1067
    CrossrefPubMedSearch in Google Scholar